Christoph Senn

Christoph Senn is an Adjunct Professor of Marketing at INSEAD and Co-Director of the INSEAD Marketing & Sales Excellence Initiative (MSEI). His passion is about helping organizations build high-value business relationships.

At INSEAD, Christoph teaches in open enrolment and custom Executive Education Programs. He frequently conducts research and transfer projects in cooperation with leading companies, such as ABB, BASF, Coca-Cola, DSM, Evonik, Geberit, General Electric, Hoffmann-La Roche, Konica-Minolta, Maersk, Microsoft, Pfizer, Rusal, Schindler, Sonos, Swiss Re, Tetra Pak, Vodafone, WMF, and Zebra.

Before joining academia, Christoph held international sales and management roles in a high-tech company. After his industry time, he founded the St.Gallen University Spin-off AMC, a consulting boutique firm where he is currently acting as Chairman. He is also the Founder and CEO of Valuecreator, a software start-up company dedicated to advancing the practice of value co-creation across industries.

Initially trained as a primary school teacher, Christoph received a Master’s Degree, a Ph.D. (summa cum laude), and a Habilitation from the University of St.Gallen. Prior to joining INSEAD, he also taught at the University of St.Gallen, Columbia Business School, Rotterdam School of Management, and Technical University of Hamburg-Harburg, and has won several teaching and research awards. He has published his work in journals such as California Management Review, Harvard Business Review, Industrial Marketing Management, Journal of Business Strategy, Research Technology Management, Wall Street Journal / MIT Sloan Management Review, and others.

Christoph retired as Lieutenant-Colonel General Staff in the Swiss Army after serving as Commander of a Mechanized Infantry Battalion. He is also President of St.Gallen Oncology Conferences, a non-profit foundation dedicated to distributing knowledge for health care professionals caring for cancer patients at the national and international level, to promote the implementation of research-based knowledge and to advance cancer care in clinical practice.